Souwer, E. T. D. http://orcid.org/0000-0003-0489-7321
Sanchez-Spitman, A.
Moes, D. J. A. R.
Gelderblom, H.
Swen, J. J.
Portielje, J. E. A.
Guchelaar, H. J.
van Gelder, T.
Article History
Received: 12 December 2022
Accepted: 16 March 2023
First Online: 17 April 2023
Declarations
:
: E.T.D. Souwer, A. Sanchez-Spitman, D.J.A.R. Moes, H.G. Gelderblom, J.J. Swen, J.E.A. Portielje, and H.J. Guchelaar declared that they have no conflict of interest. T. van Gelder: In the last 3 years, TvG has received lecture fees and consulting fees from Roche Diagnostics, Thermo Fisher, Vitaeris, CSL Behring, Astellas and Aurinia Pharma. In all cases, money has been transferred to hospital accounts, and none has been paid to his personal bank accounts. TvG does not have employment or stock ownership at any of these companies, and neither does he have patents nor patent applications.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the central medical ethics review board of the Leiden University Medical Center in Leiden, The Netherlands (27 October 2008). The CYPTAM trial was registered as NTR1509 in the Dutch Trial Register.